SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Bio NC
5 Reasons Big Biotech Could Gain 25% to 30% In The Next Year
May 22, 2017
 · 
1 min read
Lone Star Bio
The Under-The-Radar Pharma Stock Not On Investors’ List (Just Yet)
May 18, 2017
 · 
1 min read
Lone Star Bio
Researchers Study DNA From Explosives, Sam Houston State University Reveals
May 17, 2017
 · 
1 min read
Job Trends
The End Of The Road: Mirna To Cease Operations After Merger With Synlogic
May 17, 2017
 · 
1 min read
Cannabis Jobs That Require a Life Science Background Are Booming
Biotech Bay
Cannabis Jobs That Require a Life Science Background Are Booming
May 16, 2017
 · 
5 min read
3 Biotechs That Could be Taken Out This Quarter
Deals
Synlogic Takes Chance on Failed Austin Biotech, Finds Spot in the Nasdaq
May 16, 2017
 · 
2 min read
Scandal-Ridden Proove Biosciences Sells Assets, Founder and CEO Exits Amid Allegations
Lone Star Bio
Struggling XBiotech Quietly Discloses Exec Resignation
May 12, 2017
 · 
2 min read
Biotech Bay
Sweet Revenge: Job Prospects Great For Science Geeks And Nerds
May 8, 2017
 · 
1 min read
Biotech Bay
How Scientists Can Transition Into A Non-Research Career
May 8, 2017
 · 
1 min read
Biotech Bay
How To Resign From Your Life Sciences Job
May 8, 2017
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Data Presented at SABCS 2025 Demonstrated that the Endocrine Activity Index® (EAI®) May Identify Patients Most Likely to Benefit from Extended Endocrine Therapy
February 16, 2026
 · 
3 min read
Press Releases
Moleculin Launches CEO Corner Platform to Share Strategic Insights
February 13, 2026
 · 
4 min read
Press Releases
Medicenna Therapeutics Reports Third Quarter Fiscal 2026 Financial Results and Provides a Corporate Update
February 13, 2026
 · 
11 min read
Press Releases
Medicenna Announces Changes to Board Composition
February 13, 2026
 · 
6 min read
Press Releases
Digital Disruption in Life Sciences: L7 Informatics Says Competitive Advantage Will Come From Governed Execution
February 12, 2026
 · 
1 min read
Press Releases
Tvardi Therapeutics to Participate in Upcoming Investor Conferences - February 12, 2026
February 12, 2026
 · 
1 min read
Press Releases
ImmuneSensor Therapeutics Doses First Patient with Aicardi Goutières Syndrome (AGS) in Phase 1b Clinical Study of cGAS inhibitor, IMSB301
February 12, 2026
 · 
5 min read
Press Releases
Decoy Therapeutics Joins Webull Corporate Connect Service Platform
February 11, 2026
 · 
4 min read
Press Releases
IntraBio Reports Further Detail on Positive Data from Levacetylleucine Pivotal Trial for the Treatment of Ataxia-Telangiectasia
February 11, 2026
 · 
4 min read
Press Releases
Lantern Pharma to Present at the 7th Glioblastoma Drug Development Summit in Boston on February 17-19, 2026
February 11, 2026
 · 
5 min read
Load More